Endometrial Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Aug 30, 2018
- Can Transcriptomics Help Find the Right Time to Administer Chemotherapy?
CM Rey, GEN, August 2018 - DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer.
Kim Jisup et al. Cancers 2018 Aug 10(9) - Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study.
Signoroni Stefano et al. Tumori 2018 Aug 300891618792460 - The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Ryan Neil A J et al. Systematic reviews 2018 Aug 7(1) 121 - Management of Individuals at Increased Hereditary Risk
ASCO, 2018 - Identification of nine new susceptibility loci for endometrial cancer
TA O'Mara et al, Nature COmm, AUgust 9, 2018 - CLINICAL UTILITY OF PROSPECTIVE MOLECULAR CHARACTERIZATION IN ADVANCED ENDOMETRIAL CANCER.
Soumerai Tara E et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug - Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Lee Jessica et al. Gynecologic oncology 2018 Aug - Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio.
Ranola John Michael O et al. Familial cancer 2018 Jul - Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers.
Corrado Giacomo et al. Journal of experimental & clinical cancer research : CR 2018 Jul 37(1) 139
.png)
No hay comentarios:
Publicar un comentario